See more : Danske Invest Japan (DKIJAP.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Inovalon Holdings, Inc. (INOV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Inovalon Holdings, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Citra Nusantara Gemilang Tbk. (CGAS.JK) Income Statement Analysis – Financial Results
- Novateor Research Laboratories (NOVATEOR.BO) Income Statement Analysis – Financial Results
- Aveanna Healthcare Holdings Inc. (AVAH) Income Statement Analysis – Financial Results
- Holcim (Argentina) S.A. (HARG.BA) Income Statement Analysis – Financial Results
- TINC NV (TINC.BR) Income Statement Analysis – Financial Results
Inovalon Holdings, Inc. (INOV)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: http://www.inovalon.com
About Inovalon Holdings, Inc.
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 667.52M | 642.41M | 527.68M | 449.36M | 427.59M | 437.27M | 361.54M | 295.80M | 300.28M | 239.69M |
| Cost of Revenue | 167.82M | 167.81M | 144.83M | 151.05M | 159.17M | 146.14M | 112.76M | 120.05M | 101.19M | 102.70M |
| Gross Profit | 499.70M | 474.60M | 382.85M | 298.31M | 268.42M | 291.13M | 248.78M | 175.74M | 199.09M | 136.99M |
| Gross Profit Ratio | 74.86% | 73.88% | 72.55% | 66.39% | 62.78% | 66.58% | 68.81% | 59.41% | 66.30% | 57.15% |
| Research & Development | 33.50M | 33.69M | 28.64M | 27.38M | 29.15M | 22.33M | 23.13M | 21.19M | 15.50M | 14.86M |
| General & Administrative | 216.62M | 200.76M | 205.04M | 149.95M | 137.28M | 115.03M | 88.57M | 80.64M | 72.66M | 63.18M |
| Selling & Marketing | 62.94M | 62.41M | 45.53M | 34.10M | 27.08M | 14.68M | 7.14M | 5.95M | 6.79M | 6.75M |
| SG&A | 279.56M | 263.17M | 250.57M | 184.05M | 164.35M | 129.71M | 95.71M | 86.59M | 79.45M | 69.94M |
| Other Expenses | 114.93M | 108.25M | 96.73M | 53.09M | 37.28M | 22.63M | 19.88M | 15.52M | 12.90M | 11.23M |
| Operating Expenses | 427.99M | 405.11M | 375.94M | 264.52M | 230.79M | 174.68M | 138.72M | 123.30M | 107.85M | 96.02M |
| Cost & Expenses | 595.81M | 572.92M | 520.76M | 415.57M | 389.95M | 320.82M | 251.48M | 243.35M | 209.04M | 198.72M |
| Interest Income | 479.00K | 2.24M | 2.18M | 5.43M | 5.79M | 3.00M | 6.00K | 9.00K | 11.00K | 10.00K |
| Interest Expense | 56.18M | 65.83M | 50.90M | 6.23M | 5.07M | 4.42M | 1.34M | 79.00K | 129.00K | 62.00K |
| Depreciation & Amortization | 114.93M | 108.25M | 96.73M | 53.09M | 37.28M | 22.63M | 19.88M | 15.52M | 12.90M | 11.23M |
| EBITDA | 186.56M | 179.96M | 94.07M | 91.90M | 81.25M | 141.76M | 129.95M | 67.97M | 104.15M | 52.21M |
| EBITDA Ratio | 27.95% | 28.01% | 17.83% | 20.45% | 19.00% | 32.42% | 35.94% | 22.98% | 34.68% | 21.78% |
| Operating Income | 71.71M | 69.49M | 6.92M | 33.79M | 37.63M | 116.46M | 110.06M | 52.45M | 91.24M | 40.97M |
| Operating Income Ratio | 10.74% | 10.82% | 1.31% | 7.52% | 8.80% | 26.63% | 30.44% | 17.73% | 30.38% | 17.09% |
| Total Other Income/Expenses | -56.25M | -63.61M | -60.47M | -1.20M | 1.27M | -1.75M | -1.33M | -70.00K | -118.00K | -52.00K |
| Income Before Tax | 15.46M | 5.88M | -53.56M | 32.59M | 38.90M | 114.71M | 108.73M | 52.38M | 91.12M | 40.92M |
| Income Before Tax Ratio | 2.32% | 0.91% | -10.15% | 7.25% | 9.10% | 26.23% | 30.07% | 17.71% | 30.34% | 17.07% |
| Income Tax Expense | -7.12M | -1.90M | -14.39M | -2.23M | 11.80M | 48.65M | 43.38M | 19.66M | 35.96M | 15.99M |
| Net Income | 22.58M | 7.78M | -39.16M | 34.82M | 27.10M | 66.06M | 65.35M | 32.72M | 55.16M | 24.93M |
| Net Income Ratio | 3.38% | 1.21% | -7.42% | 7.75% | 6.34% | 15.11% | 18.08% | 11.06% | 18.37% | 10.40% |
| EPS | 0.15 | 0.05 | -0.27 | 0.24 | 0.18 | 0.45 | 0.53 | 1.47 | 2.48 | 1.12 |
| EPS Diluted | 0.15 | 0.05 | -0.27 | 0.24 | 0.18 | 0.45 | 0.53 | 1.47 | 2.48 | 1.12 |
| Weighted Avg Shares Out | 149.72M | 148.63M | 145.39M | 142.23M | 150.05M | 145.75M | 122.26M | 22.22M | 22.22M | 22.22M |
| Weighted Avg Shares Out (Dil) | 149.72M | 148.63M | 145.39M | 142.74M | 150.96M | 148.28M | 122.26M | 22.22M | 22.22M | 22.22M |
Inovalon Data Powers New Insights on Diverse Healthcare Populations
Humana (HUM), Inovalon Expands Ties for Vaccine Adherence Efforts
Humana Expands Use of the Inovalon ONE® Platform
AIDS Healthcare Foundation Selects the Inovalon ONE® Platform
Inovalon Holdings, Inc. (INOV) CEO Keith Dunleavy on Q4 2020 Results - Earnings Call Transcript
Inovalon Reports Fourth Quarter and Full Year 2020 Results
Inovalon Supports Centers for Medicare and Medicaid Services with Software Application for COVID-19 Vaccine Administration
Inovalon Announces Fourth Quarter and Full Year 2020 Earnings Conference Call
Inovalon Reports Preliminary Fourth Quarter 2020 Results
Inovalon to Present at 23rd Annual Needham Growth Conference
Source: https://incomestatements.info
Category: Stock Reports